Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: Effect of the structure of acidic groups

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 4, 2008, Pages 1035-1041

  Sou, Keitaro ^a   Tsuchida, Eishun ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Acidic lipid; Anionic surface; Complement activation; Electrostatic interaction; Liposome

Indexed keywords

CARBOXYLIC ACID DERIVATIVE;

ACIDITY; ARTICLE; COMPLEMENT ACTIVATION; ELECTROPHORETIC MOBILITY; MEMBRANE STRUCTURE; PHOSPHOLIPID VESICLE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ANIMALS; CALCIUM; COMPLEMENT ACTIVATION; ELECTROSTATICS; LYSINE; MALE; PHOSPHOLIPIDS; RATS; RATS, WISTAR; UNILAMELLAR LIPOSOMES;

EID: 40949144499     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.01.006     Document Type: Article

References (33)

1. Loughrey H.C., Bally M.B., Reinish L.M., and Cullis P.R. The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement. Thromb. Haemost. 64 (1990) 172-176
2. Chonn A., Cullis P.R., and Devine D.V. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146 (1991) 4234-4241
3. Szebeni J. The interaction of liposomes with the complement system. Crit. Rev. Ther. Drug Carr. Syst. 15 (1998) 57-88
4. Moghimi S.M., Hamad I., Andresen T.L., Jorgensen K., and Szebeni J. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. FASEB J. 20 (2006) 2591-2593
5. Bradley A.J., Brooks D.E., Norris-Jones R., and Devine D.V. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner. Biochim. Biophys. Acta 1418 (1999) 19-30
6. Bradley A.J., Maurer-Spurej E., Brooks D.E., and Devine D.V. Unusual electrostatic effects on binding of C1q to anionic liposomes: role of anionic phospholipid domains and their line tension. Biochemistry 38 (1999) 8112
7. Jiang H., Cooper B., Robey F.A., and Gewurz H. DNA binds and activates complement via residues 14-26 of the human C1q A chain. J. Biol. Chem. 267 (1992) 25597-25601
8. Jiang H., Burdick D., Glabe C.G., Cotman C.W., and Tenner A.J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152 (1994) 5050-5059
9. Bradley A.J., Devine D.V., Ansell S.M., Janzen J., and Brooks D.E. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch. Biochem. Biophys. 357 (1998) 185-194
10. In: Tsuchida E. (Ed). Substitute: Present and Future Perspective (1998), Elsevier Science, Amsterdam
11. Takeoka S., Ohgushi T., Terase K., Ohmori T., and Tsuchida E. Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 12 (1996) 1755-1759
12. Sakai H., Hamada K., Takeoka S., Nishide H., and Tsuchida E. Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol Prog. 12 (1996) 119-125
13. Sou K., Naito Y., Endo T., Takeoka S., and Tsuchida E. Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol Prog. 19 (2003) 1547-1552
14. Sakai H., Horinouchi H., Yamamoto M., Ikeda E., Takeoka S., Takaori M., Tsuchida E., and Kobayashi K. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: degradation of HbV and erythropoiesis in a rat spleen for 2 weeks. Transfusion 46 (2006) 339-347
15. Sakai H., Masada Y., Horinouchi H., Ikada E., Sou K., Takeoka S., Suematsu M., Takaori M., Kobayashi K., and Tsuchida E. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J. Pharmacol. Exp. Ther. 311 (2004) 874-884
16. Sou K., Klipper R., Goins B., Tsuchida E., and Phillips W.T. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J. Pharmacol. Exp. Ther. 312 (2005) 702-709
17. Abe H., Fujihara M., Azuma H., Ikeda H., Ikebuchi K., Takeoka S., Tsuchida E., and Harashima H. Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: effects on coagulation, kallikrein-kinin, and complement systems. Artif. Cells Blood Substit. Biotechnol. 34 (2006) 1-10
18. Abe H., Azuma H., Yamaguchi M., Fujihara M., Ikeda H., Sakai H., Takeoka S., and Tsuchida E. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats. Artif. Cells Blood Substit. Biotechnol. 35 (2007) 157-172
19. Sou K., Goins B., Takeoka S., Tsuchida E., and Phillips W.T. Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo. Biomaterials 28 (2007) 2655-2666
20. Sou K., Endo T., Takeoka S., and Tsuchida E. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjug. Chem. 11 (2000) 372-379
21. Sakai H., Hisamoto S., Fukutomi I., Sou K., Takeoka S., and Tsuchida E. Detection of lipopolysaccharide in hemoglobin-vesicles by Limulus amebocyte lysate test with kinetic-turbidimetric gel clotting analysis and pretreatment of surfactant. J. Pharm. Sci. 93 (2004) 310-321
22. McLaughlin S. The electrostatic properties of membranes. Annu. Rev. Biophys. Biophys. Chem. 18 (1989) 113-136
23. Watts A., Harlos K., Maschke W., and Marsh D. Control of the structure and fluidity of phosphatidylglycerol bilayers by pH titration. Biochim. Biophys. Acta 510 (1978) 63-74
24. Tocanne J.F., and Teissié J. Ionization of phospholipids and phospholipid-supported interfacial lateral diffusion of protons in membrane model systems. Biochim. Biophys. Acta 1031 (1990) 111-142
25. 2+-binding domain. J. Biol. Chem. 273 (1998) 15879-15882
26. Murphy J.E., Tacon D., Tedbury P.R., Hadden J.M., Knowling S., Sawamura T., Peckham M., Phillips S.E., Walker J.H., and Ponnambalam S. LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem. J. 393 (2006) 107-115
27. Lau A., McLaughlin A., and McLaughlin S. The adsorption of divalent cations to phosphatidylglycerol bilayer membranes. Biochim. Biophys. Acta 645 (1981) 279-292
28. Sinn C.G., Antonietti M., and Dimova R. Binding of calcium to phosphatidylcholine-phosphatidylserine membranes. Colloids and Surfaces A: Physicochem. Eng. Aspects 282-283 (2006) 410-419
29. 2+ to phospholipid phosphate group. J. Chromatogr. A 1150 (2007) 339-347
30. Volodkin D., Ball V., Schaaf P., Voegel J.C., and Mohwald H. Complexation of phosphocholine liposomes with polylysine. Stabilization by surface coverage versus aggregation. Biochim. Biophys. Acta 1768 (2007) 280-290
31. Murray D., Arbuzova A., Hangyás-Mihályné G., Gambhir A., Ben-Tal N., Honig B., and MaLaughlin S. Electrostatic properties of membranes containing acidic lipids and adsorbed basic peptides: theory and experiment. Biophys. J. 77 (1999) 3176-3188
32. Arlaud G.J., Gaboriaud C., Thielens N.M., Budayova-Spano M., Rossi V., and Fontecilla-Camps J.C. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol. Immunol. 39 (2002) 383-394
33. O'Brien G., Quinsey N.S., Whisstock J.C., and Pike R.N. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates. Biochemistry 42 (2003) 14939-14945